Holen Sie sich die Stockscreener-App
9.64
10.97%
-1.11
Schlusskurs vom Vortag:
$10.75
Offen:
$10.66
24-Stunden-Volumen:
746.60K
Relative Volume:
2.27
Marktkapitalisierung:
$390.07M
Einnahmen:
$825.37M
Nettoeinkommen (Verlust:
$-60.01M
KGV:
-6.4177
EPS:
-1.5021
Netto-Cashflow:
$-4.46M
1W Leistung:
-20.83%
1M Leistung:
-22.50%
6M Leistung:
-40.70%
1J Leistung:
-13.77%
1-Tages-Spanne:
$9.47
$10.66
1-Wochen-Bereich:
$9.47
$12.34
52-Wochen-Spanne:
$9.47
$16.99
Orthofix Medical Inc Stock (OFIX) Company Profile
Firmenname
Orthofix Medical Inc
Sektor
Branche
Telefon
214-937-2000
Adresse
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
9.65 | 434.53M | 825.37M | -60.01M | -4.46M | -1.5021 |
ABT
Abbott Laboratories
|
86.61 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.15 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.83 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.77 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.75 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | TD Cowen | Hold |
| 2025-10-28 | Fortgesetzt | Stifel | Buy |
| 2025-01-22 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-08 | Hochstufung | Stifel | Hold → Buy |
| 2024-05-08 | Hochstufung | ROTH MKM | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-09-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-09-12 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-19 | Fortgesetzt | BTIG Research | Buy |
| 2022-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2019-10-29 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-06-21 | Eingeleitet | BTIG Research | Buy |
| 2017-06-14 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-05-23 | Eingeleitet | SunTrust | Buy |
| 2015-07-10 | Eingeleitet | Sidoti | Buy |
| 2013-05-09 | Herabstufung | Mizuho | Buy → Neutral |
| 2013-01-08 | Bestätigt | Mizuho | Buy |
| 2010-06-21 | Eingeleitet | Boenning & Scattergood | Outperform |
| 2010-03-09 | Bestätigt | Jefferies & Co | Buy |
| 2010-02-18 | Hochstufung | Susquehanna Financial | Neutral → Positive |
| 2010-01-22 | Eingeleitet | Jefferies & Co | Buy |
| 2009-11-03 | Hochstufung | Wells Fargo | Underperform → Market Perform |
| 2009-07-31 | Bestätigt | Jefferies & Co | Buy |
| 2009-07-31 | Hochstufung | Thomas Weisel | Market Weight → Overweight |
| 2009-05-26 | Bestätigt | Jefferies & Co | Buy |
| 2009-04-17 | Herabstufung | Wachovia | Mkt Perform → Underperform |
| 2009-02-19 | Eingeleitet | Canaccord Adams | Buy |
| 2008-07-07 | Herabstufung | Wachovia | Outperform → Mkt Perform |
Alle ansehen
Orthofix Medical Inc Aktie (OFIX) Neueste Nachrichten
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX) - PR Newswire
Discipline and Rules-Based Execution in OFIX Response - Stock Traders Daily
Orthofix lowers outlook on Medicare changes to bone growth stimulators - MSN
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
OFIX Maintains Rating by Barrington Research -- Price Target Low - GuruFocus
Barrington Adjusts Price Target on Orthofix Medical to $15 From $17, Maintains Outperform Rating - Moomoo
Stifel cuts Orthofix Medical stock price target on reimbursement hit - Investing.com
Stifel cuts Orthofix Medical stock price target on reimbursement hit By Investing.com - Investing.com Nigeria
TD Cowen cuts Orthofix Medical stock price target on CMS rate cuts By Investing.com - Investing.com South Africa
TD Cowen cuts Orthofix Medical stock price target on CMS rate cuts - Investing.com UK
Canaccord cuts Orthofix Medical stock price target on reimbursement headwinds By Investing.com - Investing.com South Africa
Canaccord cuts Orthofix Medical stock price target on reimbursement headwinds - Investing.com Australia
Orthofix (OFIX) Faces Financial Outlook Adjustment Following FDA Reclassification - GuruFocus
OrthoFix Medical Withdraws Three-Year Financial Targets Following FDA Reclassification and CMS Reimbursement Changes - Minichart
Orthofix (OFIX) Revises Financial Projections for Next Three Yea - GuruFocus
Orthofix (OFIX) Lowers FY Revenue Outlook, Shares Plunge - GuruFocus
OFIX Stock Drops in Morning Trading - GuruFocus
Orthofix Medical updates 2026 outlook following Medicare reimbursement changes By Investing.com - Investing.com South Africa
Orthofix Cuts 2026 Outlook After Medicare Reimbursement Changes - TipRanks
Orthofix Medical updates 2026 outlook following Medicare reimbursement changes - Investing.com
Orthofix Medical : Investor PresentationMay 21, 2026 - marketscreener.com
Orthofix Medical updates 2026 outlook after CMS Medicare cuts for bone growth stimulators - TradingView
Medicare cuts push Orthofix (NASDAQ: OFIX) to lower 2026 outlook and scrap 3-year goals - Stock Titan
Orthofix Medical Signals Gradual Turn in Earnings Call - TipRanks
Orthofix Medical Inc stock (US6875231068): spine specialist in focus after recent setbacks and restr - AD HOC NEWS
Orthofix to Participate in Upcoming Investor Conferences - Ortho Spine News
How The Orthofix Medical (OFIX) Investment Story Is Resetting After New Guidance And Targets - Yahoo Finance
Orthofix Medical Inc stock (US6875231068): spine specialist in focus after latest guidance and leade - AD HOC NEWS
Orthofix Medical Inc.Common Stock (NQ: OFIX - The Chronicle-Journal
Armistice Capital (OFIX) reports 2.7M shares, 6.73% stake in Orthofix - Stock Titan
Behavioral Patterns of OFIX and Institutional Flows - Stock Traders Daily
Orthofix Medical stock (US6875231068): Brokerages rate Hold with $17.25 target - AD HOC NEWS
Orthofix Medical Inc. (NASDAQ:OFIX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Bone Growth Stimulators Market to Reach US$ 2.70 Billion by 2033 - openPR.com
Orthofix reshuffles spine division leadership, posts preliminary Q1 sales - MSN
Insider Buying: HENNEMAN JOHN B III Acquires 5,000 Shares of Ort - GuruFocus
Orthofix (OFIX) director John Henneman buys 5,000 shares at $12.26 - Stock Titan
US$17.25: That's What Analysts Think Orthofix Medical Inc. (NASDAQ:OFIX) Is Worth After Its Latest Results - simplywall.st
Orthofix Medical Inc. (NASDAQ:OFIX) Just Reported, And Analysts Assigned A US$17.25 Price Target - Yahoo Finance
Orthofix Medical Inc. (OFIX) Stock Analysis: Evaluating The 42.92% Potential Upside - DirectorsTalk Interviews
Orthofix (OFIX) Unveils Innovations in Pediatric Limb Reconstruc - GuruFocus
Engine capital funds acquire $2.23m of Orthofix Medical shares By Investing.com - Investing.com South Africa
Orthofix Medical Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:OFIX) 2026-05-07 - Seeking Alpha
Engine capital funds acquire $2.23m of Orthofix Medical shares - Investing.com UK
Engine Capital (NASDAQ: OFIX) funds add 184,896 Orthofix Medical shares in open-market buys - Stock Titan
Orthofix (OFIX) Q1 2026 Earnings Transcript - AOL.com
Orthofix to Report First Quarter 2026 Financial Results - Quantisnow
Finanzdaten der Orthofix Medical Inc-Aktie (OFIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orthofix Medical Inc-Aktie (OFIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Engine Capital Management, LP | 10% Owner |
May 05 '26 |
Buy |
11.99 |
112,950 |
1,354,587 |
3,783,131 |
| Engine Capital Management, LP | 10% Owner |
May 06 '26 |
Buy |
12.23 |
41,946 |
512,916 |
3,821,285 |
| Engine Capital Management, LP | 10% Owner |
May 07 '26 |
Buy |
12.18 |
30,000 |
365,425 |
3,848,573 |
| Cedron Jorge Andres | CLO |
Apr 16 '26 |
Sale |
12.82 |
3,743 |
47,985 |
59,006 |
| Vitale Lucas | CP&BOO |
Mar 17 '26 |
Sale |
11.92 |
4,269 |
50,886 |
160,449 |
| CAPPS VICKIE L | Director |
Mar 09 '26 |
Buy |
12.48 |
2,500 |
31,200 |
25,085 |
| CAPPS VICKIE L | Director |
Mar 10 '26 |
Buy |
12.45 |
2,500 |
31,124 |
27,585 |
| Andrews Julie | CFO |
Mar 04 '26 |
Sale |
12.92 |
2,425 |
31,322 |
91,109 |
| Andrews Julie | CFO |
Mar 05 '26 |
Sale |
12.55 |
2,363 |
29,658 |
88,746 |
| Vitale Lucas | CP&BOO |
Mar 04 '26 |
Sale |
12.92 |
1,171 |
15,125 |
165,859 |
0.32%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):